African American ethnicity is not associated with development of Barrett's oesophagus after erosive oesophagitis
- PMID: 26188839
- DOI: 10.1016/j.dld.2015.06.007
African American ethnicity is not associated with development of Barrett's oesophagus after erosive oesophagitis
Abstract
Background: Barrett's oesophagus is the primary risk factor for oesophageal adenocarcinoma; erosive oesophagitis is considered an intermediate step with Barrett's oesophagus development potential upon healing. Barrett's oesophagus occurs in 9-19% following erosive oesophagitis but minimal data exists in African Americans. The study aim was to determine if ethnicity is associated with Barrett's oesophagus formation following erosive oesophagitis.
Methods: Retrospective review of endoscopies from September 2007 to December 2012 was performed. Inclusion criteria were erosive oesophagitis on index endoscopy, repeat endoscopy ≥6 weeks later and non-Hispanic white or African American ethnicity. Barrett's oesophagus frequency following erosive oesophagitis by ethnicity was compared.
Results: A total of 14,303 patients underwent endoscopy during the study period; 1636 had erosive oesophagitis. Repeat endoscopy was performed on 125 non-Hispanic white or African American patients ≥6 weeks from the index procedure. Barrett's oesophagus occurred in 8% of non-Hispanic whites while no African American developed it on repeat endoscopy following erosive oesophagitis (p=0.029). No significant difference was seen between ethnic groups in any clinical parameter assessed.
Conclusions: African American ethnicity appears to result in decreased Barrett's oesophagus formation following erosive oesophagitis. Further investigation to demonstrate factors resulting in decreased Barrett's oesophagus formation among African Americans should be performed.
Keywords: African Americans; Barrett's oesophagus; Erosive oesophagitis; Ethnicity; GERD.
Copyright © 2015. Published by Elsevier Ltd.
Similar articles
-
Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.Aliment Pharmacol Ther. 1997 Feb;11(1):147-56. doi: 10.1046/j.1365-2036.1997.114285000.x. Aliment Pharmacol Ther. 1997. PMID: 9042987 Clinical Trial.
-
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x. Aliment Pharmacol Ther. 2006. PMID: 16393313
-
Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.World J Gastroenterol. 2009 Jun 21;15(23):2878-81. doi: 10.3748/wjg.15.2878. World J Gastroenterol. 2009. PMID: 19533809 Free PMC article.
-
Barrett's oesophagus: optimal strategies for prevention and treatment.Drugs. 2003;63(6):555-64. doi: 10.2165/00003495-200363060-00003. Drugs. 2003. PMID: 12656653 Review.
-
Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia.Aliment Pharmacol Ther. 2004 Oct;20 Suppl 5:40-7; discussion 61-2. doi: 10.1111/j.1365-2036.2004.02132.x. Aliment Pharmacol Ther. 2004. PMID: 15456463 Review.
Cited by
-
Mapping the adult human esophagus in vivo and in vitro.Development. 2022 Oct 15;149(20):dev200614. doi: 10.1242/dev.200614. Epub 2022 Oct 24. Development. 2022. PMID: 36278875 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources